La Roche-Posay has announced the launch of its Mela B3 Dark Spot Serum & Mela B3 UV Daily Moisturizer SPF 30 products.

Powered by Melasyl™, the manufacturer said in a news release, L'Oreal's multi-patented ingredient derived from 18 years of research, represents "a breakthrough in pigmentation science for addressing skin discoloration."

Mela B3 Serum, according to the news release, is the first dermatological discoloration and dark spot solution powered by Melasyl™ with 10% Niacinamide, which it says visibly reduces a range of skin discoloration while respecting the natural tone of all skin types. Tested on all skin tones, the product addresses sunspots, age spots, post-acne marks, and persistent dark spots with long-lasting results.

Complementing the serum, Mela B3 UV Daily Moisturizer SPF 30 offers protection against visible signs of sun damage caused by ultraviolet A (UVA) and ultraviolet B (UVB) exposure.

Dermatologist Dr. Valerie Callender spoke to the efficacy of these products in addressing facial skin discoloration and uneven skin tone.

"Discoloration is a common complaint by patients, which occurs in all skin types. Mela B3 serum with Melasyl™ & Niacinamide will improve facial skin discoloration, fade dark spots, and correct uneven skin tone," Dr. Callender, a board-certified dermatologist, said in the news release. "Mela B3 Lightweight SPF 30 Sunscreen is formulated with Melasyl™ to correct existing dark spots while preventing post-inflammatory hyperpigmentation and discoloration from occurring. I recommend daily use of Mela B3 UV, which provides broad spectrum protection from UVA and UVB light."

Source: La Roche-Posay news release. April 25, 2024.